Re-Treatment Study of Probuphine in Opioid Addiction
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
Probuphine (buprenorphine implant) is an investigational implant placed just below the skin
containing buprenorphine (BPN). BPN is an approved treatment for opioid dependence. This is a
6-month, open-label, re-treatment study that will confirm the safety and efficacy of
Probuphine in patients who have previously completed the 6-month PRO-806 study with either
Probuphine, placebo or sublingual buprenorphine.